Testing effectiveness (Phase 2)Looking for participantsNCT06598943
What this trial is testing
Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Who this might be right for
Ulcerative ColitisUlcerative Colitis Chronic
Eli Lilly and Company 140